These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3741316)

  • 1. Morphological and clinical significance of cell kinetics in non-Hodgkin's lymphomas.
    Del Bino G; Silvestrini R; Costa A; Veneroni S; Giardini R
    Basic Appl Histochem; 1986; 30(2):197-202. PubMed ID: 3741316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Labeling index as a prognostic marker in non-Hodgkin's lymphomas.
    Costa A; Bonadonna G; Villa E; Valagussa P; Silvestrini R
    J Natl Cancer Inst; 1981 Jan; 66(1):1-5. PubMed ID: 6935451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic relevance of non-Hodgkin's lymphomas cell cycle data.
    Vucković J; Forenpoher G; Marusić M; UZarević B; Zemunik T
    Neoplasma; 1998; 45(5):332-5. PubMed ID: 9921923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Histological classification of malignant non-Hodgkin's lymphomas and patient survival: the Kiel classification versus the working formulation].
    Nizze H; Bühring U
    Verh Dtsch Ges Pathol; 1992; 76():110-6. PubMed ID: 1283239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA synthesis and ploidy in non-Hodgkin's lymphomas demonstrate intrapatient variation depending on circadian stage of cell sampling.
    Smaaland R; Lote K; Sothern RB; Laerum OD
    Cancer Res; 1993 Jul; 53(13):3129-38. PubMed ID: 8319221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of malignant lymphomas].
    Huber H; Gattringer C; Lechleitner M; Gyenes T; Frommhold H; Brittinger G; Braunsteiner H
    Wien Klin Wochenschr; 1983 Feb; 95(4):93-112. PubMed ID: 6342274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of proliferative and apoptotic fractions in low grade follicle center cell-derived non-Hodgkin's lymphomas.
    Czader M; Mazur J; Pettersson M; Liliemark J; Strömberg M; Christensson B; Tribukait B; Auer G; Ost A; Porwit A
    Cancer; 1996 Mar; 77(6):1180-8. PubMed ID: 8635141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Validity of the International Prognostic Index in non-Hodgkin's lymphomas of varying grades of malignancy].
    Bettini R; Caronni F; Maino C; Marzetta K; Sala D; Saccà V; Gorini M
    Recenti Prog Med; 2003 Nov; 94(11):494-500. PubMed ID: 14679917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low proliferative activity is associated with a favorable prognosis in peripheral T-cell lymphoma.
    Grierson HL; Wooldridge TN; Purtilo DT; Pierson J; Bast M; Wooldridge L; Armitage JO; Weisenburger DD
    Cancer Res; 1990 Aug; 50(16):4845-8. PubMed ID: 2379148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical relevance of the Kiel classification of non-Hodgkin's lymphomas (author's transl)].
    Stacher A; Heinz R; Waldner R; Böhnel J
    Wien Klin Wochenschr; 1980 Aug; 92(15):520-5. PubMed ID: 7001765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma.
    Pinto AE; Cabeçadas J; Nóbrega SD; Mendonça E
    Diagn Cytopathol; 2003 Oct; 29(4):194-9. PubMed ID: 14506670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nucleolar organizer as a marker of malignancy grade and prognosis of non-Hodgkin's malignant lymphoma].
    Raĭkhlin NT; Bukaeva IA; Probatova NA; Smirnova EA; Tupitsyn NN; Sholokhova EN
    Arkh Patol; 1996; 58(4):22-8. PubMed ID: 8967858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment outcome and prognostic factors for relapse after high-dose chemotherapy and peripheral blood stem cell rescue for patients with poor risk high grade non-Hodgkin's lymphoma.
    Lee SM; Ryder WD; Clemons MJ; Morgenstern GR; Chang J; Scarffe JH; Radford JA
    Bone Marrow Transplant; 1999 Aug; 24(3):271-7. PubMed ID: 10455365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometric analysis of low grade B-cell non-Hodgkin's lymphoma: correlation between histology, immunophenotyping and cell cycle analysis.
    Lackowska B; Wasilewska A; Gruchała A; Ryś J; Szklarski W; Niezabitowski A
    Pol J Pathol; 1994; 45(4):263-9. PubMed ID: 7697327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cytology, histology and prevalence of cell types in canine lymphoma classified according to the National Cancer Institute Working Formulation.
    Carter RF; Valli VE; Lumsden JH
    Can J Vet Res; 1986 Apr; 50(2):154-64. PubMed ID: 3756669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer: implications of tumor cell kinetics on clinical outcome.
    Daidone MG; Silvestrini R; Ventura L; Coltro Campi C; Salvadori B; Bartoli C
    Basic Appl Histochem; 1986; 30(2):221-6. PubMed ID: 3741318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation.
    Peniket AJ; Ruiz de Elvira MC; Taghipour G; Cordonnier C; Gluckman E; de Witte T; Santini G; Blaise D; Greinix H; Ferrant A; Cornelissen J; Schmitz N; Goldstone AH;
    Bone Marrow Transplant; 2003 Apr; 31(8):667-78. PubMed ID: 12692607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma.
    Vail DM; Kisseberth WC; Obradovich JE; Moore FM; London CA; MacEwen EG; Ritter MA
    Exp Hematol; 1996 Jun; 24(7):807-15. PubMed ID: 8647231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous stem cell transplantation for aggressive non-Hodgkin's lymphomas in first complete or partial remission: a retrospective analysis of the outcome of 52 patients according to the age-adjusted International Prognostic Index.
    Fanin R; Silvestri F; Geromin A; Infanti L; Sperotto A; Cerno M; Stocchi R; Savignano C; Rinaldi C; Damiani D; Baccarani M
    Bone Marrow Transplant; 1998 Feb; 21(3):263-71. PubMed ID: 9489649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.